152 related articles for article (PubMed ID: 23788841)
1. The effect of oral contraceptives on aromatase and Cox-2 expression in the endometrium of patients with idiopathic menorrhagia or adenomyosis.
Maia H; Haddad C; Pinheiro N; Casoy J
Int J Womens Health; 2013; 5():293-9. PubMed ID: 23788841
[TBL] [Abstract][Full Text] [Related]
2. Effect of oral contraceptives on vascular endothelial growth factor, Cox-2 and aromatase expression in the endometrium of uteri affected by myomas and associated pathologies.
Maia H; Casoy J; Pimentel K; Correia T; Athayde C; Cruz T; Coutinho EM
Contraception; 2008 Dec; 78(6):479-85. PubMed ID: 19014794
[TBL] [Abstract][Full Text] [Related]
3. Effect of the menstrual cycle and oral contraceptives on aromatase and cyclooxygenase-2 expression in adenomyosis.
Maia H; Casoy J; Correia T; Freitas L; Pimentel K; Athayde C; Coutinho E
Gynecol Endocrinol; 2006 Oct; 22(10):547-51. PubMed ID: 17135033
[TBL] [Abstract][Full Text] [Related]
4. Activation of NF-kappaB and COX-2 expression is associated with breakthrough bleeding in patients using oral contraceptives in extended regimens.
Maia H; Casoy J; Correia T; Athayde C; Valente J; Coutinho EM
Gynecol Endocrinol; 2010 Apr; 26(4):265-9. PubMed ID: 19757243
[TBL] [Abstract][Full Text] [Related]
5. Aromatase expression in the eutopic endometrium of myomatous uteri: the influence of the menstrual cycle and oral contraceptive use.
Maia H; Pimentel K; Casoy J; Correia T; Freitas LA; Zausner B; Athayde C; Coutinho E
Gynecol Endocrinol; 2007 Jun; 23(6):320-4. PubMed ID: 17616855
[TBL] [Abstract][Full Text] [Related]
6. Effect of a hormone-releasing intrauterine system (Mirena(®)) on aromatase and Cox-2 expression in patients with adenomyosis submitted or not, to endometrial resection.
Maia H; Haddad C; Casoy J; Maia R; Pinheiro N; Coutinho EM
Int J Womens Health; 2012; 4():175-83. PubMed ID: 22532781
[TBL] [Abstract][Full Text] [Related]
7. Non-contraceptive health benefits of oral contraceptives.
Maia HJ; Casoy J
Eur J Contracept Reprod Health Care; 2008 Mar; 13(1):17-24. PubMed ID: 17963179
[TBL] [Abstract][Full Text] [Related]
8. Endometrial morphometry in users of intrauterine contraceptive devices and women with ovulatory dysfunctional uterine bleeding: a comparison with normal endometrium.
Wang IY; Russell P; Fraser IS
Contraception; 1995 Apr; 51(4):243-8. PubMed ID: 7796590
[TBL] [Abstract][Full Text] [Related]
9. The effect of oral contraceptives on aromatase expression in the eutopic endometrium of patients with endometriosis.
Maia H; Casoy J; Correia T; Freitas LA; Pimentel K; Athayde C
Gynecol Endocrinol; 2008 Mar; 24(3):123-8. PubMed ID: 18335325
[TBL] [Abstract][Full Text] [Related]
10. Effect of switching with oral contraceptives.
Wassef SA; Sami G; Hamid EA
Egypt Popul Fam Plann Rev; 1970 Jun; 3(1):77-93. PubMed ID: 12254511
[TBL] [Abstract][Full Text] [Related]
11. Cyclooxygenase-2 expression in the endometrium and its relationship to bleeding in users of continuous oral contraceptives.
Maia H; Correia T; Freitas L; Athayde C; Coutinho EM
Gynecol Endocrinol; 2006 Feb; 22(2):96-100. PubMed ID: 16603435
[TBL] [Abstract][Full Text] [Related]
12. Expression of CD56 in patients with adenomyosis and its correlation with dysmenorrhea.
Wang F; Shi X; Qin X; Wen Z; Zhao X; Li C
Eur J Obstet Gynecol Reprod Biol; 2015 Nov; 194():101-5. PubMed ID: 26344352
[TBL] [Abstract][Full Text] [Related]
13. Effect of the menstrual cycle and oral contraceptives on cyclooxygenase-2 expression in the endometrium.
Maia H; Maltez A; Studard E; Zausner B; Athayde C; Coutinho E
Gynecol Endocrinol; 2005 Jul; 21(1):57-61. PubMed ID: 16048803
[TBL] [Abstract][Full Text] [Related]
14. Surface vascularization and endometrial appearance in women with menorrhagia or using levonorgestrel contraceptive implants. Implications for the mechanisms of breakthrough bleeding.
Hickey M; Fraser IS
Hum Reprod; 2002 Sep; 17(9):2428-34. PubMed ID: 12202436
[TBL] [Abstract][Full Text] [Related]
15. Estrogen degrades Scribble in endometrial epithelial cells through E3 ubiquitin ligase HECW1 in the development of diffuse adenomyosis†.
Jin Z; Liu H; Xu C
Biol Reprod; 2020 Feb; 102(2):376-387. PubMed ID: 31616916
[TBL] [Abstract][Full Text] [Related]
16. Aromatase and cyclooxygenase-2 expression in endometrial polyps during the menstrual cycle.
Maia H; Pimentel K; Silva TM; Freitas LA; Zausner B; Athayde C; Coutinho EM
Gynecol Endocrinol; 2006 Apr; 22(4):219-24. PubMed ID: 16723309
[TBL] [Abstract][Full Text] [Related]
17. [Role of estrogen, estrogen receptors, and aromatase in the pathogenesis of uterine adenomyosis].
Zeng YY; Guan YG; Li KY
Nan Fang Yi Ke Da Xue Xue Bao; 2017 Mar; 37(3):383-387. PubMed ID: 28377357
[TBL] [Abstract][Full Text] [Related]
18. The role of pathologic evaluation of endometrial ablation resections in predicting ablation failure and adenomyosis in hysterectomy.
Busca A; Parra-Herran C
Pathol Res Pract; 2016 Sep; 212(9):778-82. PubMed ID: 27461823
[TBL] [Abstract][Full Text] [Related]
19. Expression of progesterone receptor mRNA in the endometrium during the normal menstrual cycle and in Norplant users.
Lau TM; Witjaksono J; Affandi B; Rogers PA
Hum Reprod; 1996 Dec; 11(12):2629-34. PubMed ID: 9021364
[TBL] [Abstract][Full Text] [Related]
20. Granulocyte macrophage colony-stimulating factor in adenomyosis and autologous endometrium.
Propst AM; Quade BJ; Nowak RA; Stewart EA
J Soc Gynecol Investig; 2002; 9(2):93-7. PubMed ID: 11963838
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
